News | Nuclear Imaging | November 15, 2018

GE Healthcare Recalls Millennium Nuclear Medicine Systems

Class I recall initiated due to risk of detector detaching and falling; no patient injuries have been reported

GE Healthcare Recalls Millennium Nuclear Medicine Systems

November 15, 2018 — GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top detector detached and fell onto the detector below it. No patient injuries have been reported, although there remains a risk of potential life-threatening bodily harm if the detector were to detach and fall during a patient exam. The U.S. Food and Drug Administration (FDA) has identified this as a Class I recall, the most serious type of recall.

The Millennium MG, Millennium MC and Millennium Myosight Nuclear Medicine Systems are devices used to take images of a patient’s organs or tissues to help diagnose or treat a health condition or disease. These systems are intended for use as diagnostic imaging devices which allow the user to acquire data for high-resolution, three-dimensional images.

On Sept. 14, 2018, GE Healthcare sent customers an “Urgent Medical Device Correction Letter.” The letter instructed customers to stop using the Millennium MG, Millennium MC, and Millennium Myosight Nuclear Medicine systems until the company could complete a full and free inspection of all systems. On Nov. 6, GE Healthcare reported they had completed inspections on all Millennium MG, Millennium MC and Millennium Myosight Systems and confirmed no related issues were found.

The recall affects a total of 996 devices with the following model/item numbers:

  • NMH817;
  • NMH816;
  • NMH815;
  • NMH814;
  • NMH803;
  • NMH802;
  • NMH801;
  • NMH800;
  • NGS014;
  • NGS012;
  • NGS009;
  • NGS005; and
  • NG00.

All affected devices were manufactured between Jan. 1, 1997 and July 1, 2012, and distributed between Jan. 1, 1997 and Sept. 1, 2018.

  • Manufacturing Dates: January 1, 1997, to July 1, 2012
  • Distribution Dates: January 1, 1997, to September 1, 2018
  • Devices Recalled in the U.S.: 996

GE Healthcare has determined that the incident was caused by an improperly functioning primary motion stopper and a missing mechanical stopper which would limit the detector’s travel beyond its limits during normal operation.

In June 2013,a patient was killed because a portion of a GE Infinia Hawkeye 4 single photon emission computed tomography (SPECT)/computed tomography (CT) scanner fell during the scan at the James J. Peters VA Medical Center in the Bronx, N.Y.  The weight of nuclear imaging cameras are around 1,300 pounds or more due to it being lead-lined, plus additional lead used in the construction of the internal collimation system. This significant weight poses design challenges in these systems because of the fatigue on its supports. It is an issue that all vendors face.

The death prompted the company to initiate a Class I recall of several of its nuclear imaging systems in 2013 so they would be retrofitted with additional support. The recall, which can be read here, was expanded to most of GE’s SPECT/CT systems in July 2013.

Read the article "Patient Killed During Nuclear Imaging Scan."

Healthcare professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program. Healthcare professionals employed by facilities that are subject to FDA's user facility reporting requirements should follow the reporting procedures established by their facilities.

For more information: www.gehealthcare.com, www.fda.gov

 

Related Content

Nuclear Cardiology Optimistic About Return to Pre-COVID-19 Exam Levels. An American Society of Nuclear Cardiology (ASNC) member survey are confident nuclear cardiology volumes will return to pre-pandemic levels. #COVID19 #SARScov2
News | Nuclear Imaging | June 01, 2020
June 1, 2020 — While acknowledging the challenges their specialty is facing, more than two-thirds of respondents to a
AIR Recon DL delivers shorter scans and better image quality (Photo: Business Wire)

AIR Recon DL delivers shorter scans and better image quality (Photo: Business Wire).

News | Artificial Intelligence | May 29, 2020
May 29, 2020 — GE Healthcare announced U.S.
Largest case series (n=30) to date yields high frequency (77%) of negative chest CT findings among pediatric patients (10 months-18 years) with COVID-19, while also suggesting common findings in subset of children with positive CT findings

A and B, Unenhanced chest CT scans show minimal GGOs (right lower and left upper lobes) (arrows) and no consolidation. Only two lobes were affected, and CT findings were assigned CT severity score of 2. Image courtesy of American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | May 29, 2020
May 29, 2020 — An investigation published open-access in the ...
United Imaging's uMR OMEGA is designed to provide greater access to magnetic resonance imaging (MRI) with the world’s first ultra-wide 75-cm bore 3T MRI.
News | Magnetic Resonance Imaging (MRI) | May 27, 2020
May 27, 2020 — United Imaging's...
There were several new developments in digital radiography (DR) technology at the 2019 Radiological Society of North America (RSNA) annual meeting. These trends included integration of artificial intelligence (AI) auto detection technologies, more durable glassless detector plates, and technologies to pull more diagnostic data out of X-ray imaging. Some vendors also have redesigned their DR systems to make them more user-friendly and ergonomic. 
Feature | Digital Radiography (DR) | May 26, 2020 | By Dave Fornell
There were several new developments in digital rad...
The Breast Imaging and Reporting System (BI-RADS) was established by the American College of Radiology to help classify findings on mammography. Findings are classified based on the risk of breast cancer, with a BI-RADS 2 lesion being benign, or not cancerous, and BI-RADS 6 representing a lesion that is biopsy-proven to be malignant.

Getty Images

News | Breast Imaging | May 19, 2020
May 19, 2020 — Women with mammographically detected breast lesions that are probably benign should have follow-up sur